Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

45 results about "Deoxygenated Hemoglobin" patented technology

Hemoglobin containing a heme group that is not bound to oxygen (O2). This molecule is normally found in the systemic veins following transit through capillaries and release of O2 into the tissues. Excess deoxyhemoglobin can be associated with hypoxia.

Preserving a hemoglobin blood substitute with a transparent overwrap

The invention relates to a method for preserving the stability of a hemoglobin blood substitute comprising maintaining the hemoglobin blood substitute in an atmosphere substantially free of oxygen. The method for preserving a deoxygenated hemoglobin blood substitute comprises maintaining the deoxygenated hemoglobin blood substitute in an oxygen barrier film overwrap package. In one embodiment, the package comprises a transparent laminate material comprising an oxygen barrier layer and a polyolefin layer, wherein the laminant has a thickness of between about 0.001 and about 0.01 inches (or about 0.0254 to about 0.254 millimeters) and an oxygen permeability of less than about 0.01 cubic centimeters per 100 square inches (or about 0.01 cc per 645 square centimeters) over 24 hours at 1 atmosphere and at about 23° C. The oxygen barrier layer comprises ethylene vinyl alcohol. Aso provided herein is a preserved deoxygenated hemoglobin blood substitute comprises a deoxygenated hemoglobin blood substitute and an oxygen barrier film overwrap package. The package comprises a transparent laminant material comprising an oxygen barrier layer and a polyolefin layer. Said oxygen barrier layer has an oxygen permeability of less than about 0.01 cubic centimeters per 100 square inches (or about 0.01 cc per 645 square centimeters) over 24 hours at 1 atmosphere and at about 27° C. room temperature, wherein the deoxygenated hemoglobin blood substitute is sealed within the overwrap package. In one embodiment, the oxygen barrier layer comprises ethylene vinyl alcohol.
Owner:OPK BIOTECH

Device for measuring oxygenated hemoglobin and deoxygenated hemoglobin and brain imaging device

The invention discloses a device for measuring oxygenated hemoglobin and deoxygenated hemoglobin and a near infrared brain imaging device. The device comprises an interface module, a near infrared receiving and transmitting module and a controller, wherein the near infrared transceiving module is provided with a plug-and-play interface and plugged in the interface module through the plug-and-playinterface, the near infrared receiving and transmitting module is driven by the controller to transmit preset-wavelength near infrared rays to measured cerebral cortex and receive light intensity signals generated when the near infrared rays are reflected by the measured cerebral cortex. The controller is connected with the interface module and used for receiving the light intensity signals outputby the near infrared receiving and transmitting module and measuring parameters of oxygenated hemoglobin and deoxygenated hemoglobin of the measured cerebral cortex according to the light intensity signals. Thus, according to the characteristic that hot plug is supported by the near infrared receiving and transmitting module, the aims of increasing and decreasing functions and channel number canbe realized, and the reusability of the device and the usage rate of parts can be increased.
Owner:北京心灵方舟科技发展有限公司

Device and method for measuring oxygen-containing hemoglobin and deoxygenated hemoglobin and equipment

The invention discloses a method and device for measuring oxygen-containing hemoglobin and deoxygenated hemoglobin and equipment. The device comprises a near-infrared emission module, a near-infraredreceiving module and a controller, wherein the near-infrared emission module is used for emitting near-infrared light of target compound waveforms to the tested cerebral cortex, the near-infrared receiving module is used for receiving a luminous intensity signal, reflected by the tested cerebral cortex, of the near-infrared light, and the controller is used for receiving target measuring requirement parameters, adjusting the near-infrared light waveforms emitted by the near-infrared emission module according to the target measuring requirement parameters to obtain the target compound waveforms, controlling the near-infrared emission module to emit the near-infrared light according to the target compound waveforms, receiving luminous intensity information output by the near-infrared receiving module, and measuring oxygen-containing hemoglobin parameters and deoxygenated hemoglobin parameters of the tested cerebral cortex according to the luminous intensity information. In this way, thefunction of dynamically adjusting output waveforms to adapt to different testing items and different testees is achieved, and the using adaptability of products is improved.
Owner:北京心灵方舟科技发展有限公司

Preserving a hemoglobin blood substitute with a transparent overwrap

The invention relates to a method for preserving the stability of a hemoglobin blood substitute comprising maintaining the hemoglobin blood substitute in an atmosphere substantially free of oxygen. The invention also involves a method for producing a stable polymerized hemoglobin blood-substitute from blood. The method of this invention includes mixing blood with an anticoagulent to form a blood solution, washing the red blood cells in the blood solution and then separating the washed red blood cells from the white blood cells. This method also includes disrupting the red blood cells to release hemoglobin and form a hemoglobin solution, which is then treated by high performance liquid chromatography to form a hemoglobin eluate. The hemoglobin eluate is then deoxygenated, contacted with a first sulfhydryl compound to form an oxidation-stabilized deoxygenated hemoglobin solution, and mixed with a cross-linking agent to form a polymerization reaction mixture, which is then polymerized. The polymerized hemoglobin solution is then diafiltered with a physiologic solution and with a sulfhydryl compound, whereby the polymerized hemoglobin solution is made physiologically acceptable, and whereby the sulfhydryl compound scavenges oxygen, to form a stable polymerized hemoglobin blood-substitute, which is then packaged and stored in an atmosphere substantially free of oxygen.
Owner:OPK BIOTECH

Photoacoustic and ultrasonic bimodal imaging system and method for transplanted kidneys

InactiveCN111493816AEnable structural imagingSimultaneous real-time imaging of structuresOrgan movement/changes detectionDiagnostic recording/measuringUltrasonic sensorKidney
The invention discloses a photoacoustic ultrasonic bimodal imaging system and method for transplanted kidney. The system comprises a pulse laser which is used for the transplanted kidney to generate an photoacoustic signal; the ultrasonic transducer is used for receiving the photoacoustic signal and converting the photoacoustic signal into an electric signal; the ultrasonic transceiving module isused for transmitting and receiving electric signals; a photoacoustic signal processing unit; a data collection unit; and the computer is used for controlling the pulse laser and the ultrasonic transceiving module, performing image reconstruction on the digitized photoacoustic signal to obtain a photoacoustic image, and performing color coding on the photoacoustic image to realize development of functional information such as transplanted kidney microvascular distribution, intravascular blood oxygen content, oxygenated/deoxygenated hemoglobin content and the like. Structural imaging of the transplanted kidney can be achieved, functional information such as castruty distribution, intravascular blood oxygen content and oxygenated/deoxygenated hemoglobin content of the transplanted kidney canbe provided, and namely simultaneous real-time imaging of the structure and the function of the transplanted kidney is achieved.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV

Noninvasive exercise fatigue intervention and evaluation method

PendingCN113952633AAvoid complexityAvoid invasiveElectrotherapyDiagnostic recording/measuringTranscutaneous Acupoint Electrical StimulationUpper limb
The invention discloses a non-invasive exercise fatigue intervention and evaluation method. The method comprises the following steps: step 1, a laser acupuncture and moxibustion combined percutaneous acupoint electrical stimulation composite intervention method is adopted, and laser and current synchronous stimulation is realized by using a composite intervention probe; and step 2, an an exercise fatigue and intervention effect assessment method is adopted by means of firstly, establishing an upper limb fatigue model for exercise fatigue assessment, then establishing an exercise fatigue fusion assessment model by using indexes such as a visual simulation score table, oxygenation/deoxygenated hemoglobin concentration, surface electromyogram signals, maximum equal-length contraction tension and the like, and then adopting the fusion evaluation model for verifying the intervention effect of laser acupuncture and moxibustion combined percutaneous acupoint electrical stimulation composite intervention on exercise fatigue through a control experiment. The invention provides a new clinical thought for preventing and treating exercise fatigue, and has important significance in improving the athletic performance of athletes, reducing the risk of exercise injury and diseases and encouraging people to exercise so as to promote physical and psychological health.
Owner:TIANJIN UNIV

Cerebral blood oxygen detection system and method

The invention belongs to the field of cerebral blood oxygen detection, and provides a cerebral blood oxygen detection system. The cerebral blood oxygen detection system comprises an acquisition module and a data processing module, wherein the acquisition module comprises N groups of light sources and M groups of detectors, the N groups of the light sources and the M groups of the detectors are arranged on the same side of a to-be-detected sample, and the N groups of the light sources emit at least three kinds of near-infrared light with different wavelengths into the to-be-detected sample; at least two groups of the detectors in the M groups of the detectors respectively receive near-infrared light signals which are not absorbed by the to-be-detected sample; and the data processing module is used for processing the near-infrared light signals according to the corrected Lambert-Beer law to obtain cerebral blood oxygen information of the to-be-detected sample. The system solves the technical problems that in the prior art, when the cerebral blood oxygen information is detected, the light sources and the detectors are arranged on two sides of the to-be-detected sample respectively, an optical density signal needs to penetrate through the tissue of the to-be-detected sample, the optical path is long, interference of other chromophores except oxygen-containing hemoglobin and deoxidized hemoglobin in the calculation process is large, and the calculation result error is larger.
Owner:SHENZHEN INST OF ADVANCED TECH CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products